På grund af øget infektionsrisiko skal patienter, der får Humira, overvåges nøje for infektioner, herunder tuberkulose, under behandlingen og fem måneder efter behandlingen.
Due to an increased risk of infection, patients taking Humira must be monitored closely for infections including tuberculosis during and for 2/ 3 up to five months after treatment.